Skip to main content
SpringerLink
Log in

Retinal Hemangioblastomas

  • Chapter
  • First Online:
Von Hippel-Lindau Disease

  • 31 Accesses

Abstract

von Hippel-Lindau (VHL) ocular disease is characterized by the retinal hemangioblastoma (formerly called retinal capillary hemangioma (RCH), retinal capillary hemangioblastoma, retinal angioma, or angiomatosis retinae), which was the initial finding described by the ophthalmologist, Eugen von Hippel, himself. It is also the most common tumor type seen in patients with VHL, with 80% of patients developing retinal hemangioblastomas (RHs) by age 80. Left untreated, or if treatment is delayed, they can cause significant visual morbidity and blindness. This chapter describes the pathophysiology, evaluation, diagnosis, and treatment of RHs. Other ophthalmic findings in patients with VHL, screening and surveillance guidelines, and special situations such as childhood and pregnancy, are covered as well.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Varshney N, Kebede AA, Owusu-Dapaah H, Lather J, Kaushik M, Bhullar JS. A review of von Hippel-Lindau syndrome. J Kidney Cancer VHL. 2017;4:20. https://doi.org/10.15586/jkcvhl.2017.88.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Chew EY. Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. Trans Am Ophthalmol Soc. 2005;103:495.

    PubMed  PubMed Central  Google Scholar 

  3. Wong WT, Agrón E, Coleman HR, et al. Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease. Ophthalmology. 2008;115(1):181–8. https://doi.org/10.1016/j.ophtha.2007.03.009.

    Article  PubMed  Google Scholar 

  4. Wittebol-Post D, Hes FJ, Lips CJM. The eye in von Hippel-Lindau disease. Long-term follow-up of screening and treatment: recommendations. J Intern Med. 1998;243:555–61. https://doi.org/10.1046/j.1365-2796.1998.00338.x.

    Article  CAS  PubMed  Google Scholar 

  5. Singh AD, Shields CL, Shields JA. von Hippel-Lindau disease. Surv Ophthalmol. 2001;46(2):117. https://doi.org/10.1016/S0039-6257(01)00245-4.

    Article  CAS  PubMed  Google Scholar 

  6. Goldberg MF, Duke JR. von Hippel-Lindau disease. Histopathologic findings in a treated and an untreated eye. Am J Ophthalmol. 1968;66(4):693–705. https://doi.org/10.1016/0002-9394(68)91292-0.

    Article  CAS  PubMed  Google Scholar 

  7. Whitson JT, Welch RB, Green WR. von Hippel-Lindau disease: case report of a patient with spontaneous regression of a retinal angioma. Retina. 1986;6(4):253–9. https://doi.org/10.1097/00006982-198606040-00010.

    Article  CAS  PubMed  Google Scholar 

  8. Milewski SA. Spontaneous regression of a capillary hemangioma of the optic disc. Arch Ophthalmol. 2002;120(8):1100–1. https://doi.org/10.1001/archopht.120.8.1100.

    Article  PubMed  Google Scholar 

  9. Molina MC, Paulo JD, Donado JH. Spontaneous regression of a retinal capillary hemangioma. Retina. 2008;28(10):1554–5. https://doi.org/10.1097/IAE.0b013e318182fc41.

    Article  PubMed  Google Scholar 

  10. Schmidt D, Neumann HPH. Spontaneous regression of retinal angiomatous lesions in v. Hippel-Lindau disease (VHL). Eur J Med Res. 2005;10(12):532.

    PubMed  Google Scholar 

  11. Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol. 1999;117(3):371–8. https://doi.org/10.1001/archopht.117.3.371.

    Article  CAS  PubMed  Google Scholar 

  12. Nicholson DH, Green WR, Kenyon KR. Light and electron microscopic study of early lesions in angiomatosis retinae. Am J Ophthalmol. 1976;82(2):193–204. https://doi.org/10.1016/0002-9394(76)90418-9.

    Article  CAS  PubMed  Google Scholar 

  13. Grossniklaus HE, Thomas JW, Vignesavaran N, Jarrett WH. Retinal hemangioblastoma: a histologic, immunohistochemical, and ultrastructural evaluation. Ophthalmology. 1992;99(1):140–5. https://doi.org/10.1016/S0161-6420(92)32024-X.

    Article  CAS  PubMed  Google Scholar 

  14. Chan CC, Chew EY, Shen D, Hackett J, Zhuang Z. Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease. Mol Vis. 2005;11:697–704.

    CAS  PubMed  Google Scholar 

  15. Chan CC, Collins ABD, Chew EY. Molecular pathology of eyes with von Hippel-Lindau (VHL) disease: a review. Retina. 2007;27(1):1–7. https://doi.org/10.1097/01.iae.0000244659.62202.ee.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Chan CC, Vortmcyer AO, Chew EY, et al. VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch Ophthalmol. 1999;117(5):625–30. https://doi.org/10.1001/archopht.117.5.625.

    Article  CAS  PubMed  Google Scholar 

  17. Jakobiec FA, Font RL, Johnson FB. Angiomatosis retinae. An ultrastructural study and lipid analysis. Cancer. 1976;38(5):2042–56. https://doi.org/10.1002/1097-0142(197611)38:5<2042::AID-CNCR2820380529>3.0.CO;2-O.

    Article  CAS  PubMed  Google Scholar 

  18. Mottow-Lippa L, Tso MOM, Peyman GA, Chejfec G. von Hippel angiomatosis: a light, electron microscopic, and immunoperoxidase characterization. Ophthalmology. 1983;90(7):848–55. https://doi.org/10.1016/S0161-6420(83)34496-1.

    Article  CAS  PubMed  Google Scholar 

  19. Vortmeyer AO, Frank S, Jeong SY, et al. Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease. Cancer Res. 2003;63(21):7051–5.

    CAS  PubMed  Google Scholar 

  20. Binderup MLM, Budtz-Jørgensen E, Bisgaard ML. Risk of new tumors in von Hippel-Lindau patients depends on age and genotype. Genet Med. 2016;18:89. https://doi.org/10.1038/gim.2015.44.

    Article  CAS  PubMed  Google Scholar 

  21. McGrath LA, Mudhar HS, Salvi SM. Hemangioblastoma of the optic nerve. Surv Ophthalmol. 2019;64(2):175–84. https://doi.org/10.1016/j.survophthal.2018.10.002.

    Article  PubMed  Google Scholar 

  22. Fons Martínez MR, España Gregori E, Aviñó Martínez JA, Hernández PF. Angioma retiniano como síndrome mascarada de tumor del nervio óptico en la enfermedad de von Hippel-Lindau. Arch Soc Esp Oftalmol. 2006;81(5):293–6. https://doi.org/10.4321/s0365-66912006000500009.

    Article  PubMed  Google Scholar 

  23. Ginzburg BM, Montanera WJ, Tyndel FJ, et al. Diagnosis of von Hippel-Lindau disease in a patient with blindness resulting from bilateral optic nerve hemangioblastomas. Am J Roentgenol. 1992;159(2):403–5. https://doi.org/10.2214/ajr.159.2.1632366.

    Article  CAS  Google Scholar 

  24. Schmidt D, Neumann HPH. Retinal vascular hamartoma in von Hippel-Lindau Disease. Arch Ophthalmol. 1995;113(9):1163–7. https://doi.org/10.1001/archopht.1995.01100090089027.

    Article  CAS  PubMed  Google Scholar 

  25. Wong WT, Yeh S, Chan CC, et al. Retinal vascular proliferation as an ocular manifestation of von Hippel-Lindau disease. Arch Ophthalmol. 2008;126(5):637–43. https://doi.org/10.1001/archopht.126.5.637.

    Article  PubMed  PubMed Central  Google Scholar 

  26. de Jong PTVM, Verkaart RJF, van de Vooren MJ, Majoor-Krakauer DF, Wiegel AR. Twin vessels in von Hippel-Lindau disease. Am J Ophthalmol. 1988;105:165. https://doi.org/10.1016/0002-9394(88)90181-X.

    Article  PubMed  Google Scholar 

  27. Higashida T, Sakata K, Kanno H, Kawasaki T, Tanabe Y, Yamamoto I. Hemangioblastoma of the optic nerve—case report. Neurol Med Chir (Tokyo). 2007;47(5):215–8. https://doi.org/10.2176/nmc.47.215.

    Article  PubMed  Google Scholar 

  28. Kerr DJ, Scheithauer BW, Miller GM, Ebersold MJ, McPhee TJ. Hemangioblastoma of the optic nerve: case report. Neurosurgery. 1995;36(3):573–81. https://doi.org/10.1227/00006123-199503000-00017.

    Article  CAS  PubMed  Google Scholar 

  29. Meyerle CB, Dahr SS, Wetjen NM, et al. Clinical course of retrobulbar hemangioblastomas in von Hippel-Lindau disease. Ophthalmology. 2008;115(8):1382–9. https://doi.org/10.1016/j.ophtha.2008.01.027.

    Article  PubMed  Google Scholar 

  30. Kupersmith MJ, Berenstein A. Visual disturbances in von Hippel-Lindau disease. Ann Ophthalmol. 1981;13(2):195–7.

    CAS  PubMed  Google Scholar 

  31. In S, Miyagi J, Kojho N, Kuramoto S, Uehara M. Intraorbital optic nerve hemangioblastoma with von Hippel-Lindau disease. Case report. J Neurosurg. 1982;56(3):426–9. https://doi.org/10.3171/jns.1982.56.3.0426.

    Article  CAS  PubMed  Google Scholar 

  32. O’Reilly GV, Rumbaugh CL, Bowens M, Kido DK, Naheedy MH. Supratentorial haemangioblastoma: the diagnostic roles of computed tomography and angiography. Clin Radiol. 1981;32(4):389–92. https://doi.org/10.1016/S0009-9260(81)80276-0.

    Article  PubMed  Google Scholar 

  33. Baggenstos M, Chew E, Butman JA, Oldfield EH, Lonser RR. Progressive peritumoral edema defining the optic fibers and resulting in reversible visual loss: case report. J Neurosurg. 2008;109(2):313–7. https://doi.org/10.3171/JNS/2008/109/8/0313.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Chen X, Sanfilippo CJ, Nagiel A, et al. Early detection of retinal hemangioblastomas in von Hippel-Lindau disease using ultra-widefield fluorescein angiography. Retina. 2018;38(4):748–54. https://doi.org/10.1097/IAE.0000000000001601.

    Article  PubMed  Google Scholar 

  35. Ali SMA, Khan I, Khurram D, Kozak I. Ultra-widefield angiography with oral fluorescein in pediatric patients with retinal disease. JAMA Ophthalmol. 2018;136(5):593–4. https://doi.org/10.1001/jamaophthalmol.2018.0462.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Shields CL, Shields JA, Barrett J, Potter P. Vasoproliferative tumors of the ocular fundus: classification and clinical manifestations in 103 patients. Arch Ophthalmol. 1995;113(5):615–23. https://doi.org/10.1001/archopht.1995.01100050083035.

    Article  CAS  PubMed  Google Scholar 

  37. Heimann H, Jmor F, Damato B. Imaging of retinal and choroidal vascular tumours. In: Eye (Basingstoke), vol. 27. Nature Publishing Group; 2013. p. 208–16. https://doi.org/10.1038/eye.2012.251.

    Chapter  Google Scholar 

  38. Sagar P, Rajesh R, Shanmugam M, Konana VK, Mishra D. Comparison of optical coherence tomography angiography and fundus fluorescein angiography features of retinal capillary hemangioblastoma. Indian J Ophthalmol. 2018;66(6):872–6. https://doi.org/10.4103/ijo.IJO_1199_17.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Sagar P, Shanmugam P, Konana V, Ramanjulu R, Mishra K, Simakurthy S. Optical coherence tomography angiography in assessment of response to therapy in retinal capillary hemangioblastoma and diffuse choroidal hemangioma. Indian J Ophthalmol. 2019;67(5):701–3. https://doi.org/10.4103/ijo.IJO_1429_18.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Chou BW, Nesper PL, Jampol LM, Mirza RG. Solitary retinal hemangioblastoma findings in OCTA pre- and post-laser therapy. Am J Ophthalmol Case Rep. 2018;10:59–61. https://doi.org/10.1016/j.ajoc.2018.01.036.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Glenn G, Stolle C, Sgambati M, Al E. New mutations versus silent carrier parent as source of first generation diagnoses in a hereditary neoplastic disorder: von Hippel-Lindau disease. Proc Am Assoc Cancer Res. 1999;40:464.

    Google Scholar 

  42. Chang JH, Spraul CW, Lynn ML, Drack A, Grossniklaus HE. The two-stage mutation model in retinal hemangioblastoma. Ophthalmic Genet. 1998;19(3):123–30. https://doi.org/10.1076/opge.19.3.123.2185.

    Article  CAS  PubMed  Google Scholar 

  43. Webster AR, Maher ER, Bird AC, Gregor ZJ, Moore AT. A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology. 1999;106(3):623–9. https://doi.org/10.1016/S0161-6420(99)90127-6.

    Article  CAS  PubMed  Google Scholar 

  44. Maher ER, Bentley E, Yates JRW, et al. Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis. J Neurol Sci. 1990;100(1–2):27–30. https://doi.org/10.1016/0022-510X(90)90008-B.

    Article  CAS  PubMed  Google Scholar 

  45. Stolle C, Glenn G, Zbar B, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat. 1998;12(6):417–23. https://doi.org/10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K.

    Article  CAS  PubMed  Google Scholar 

  46. Maher ER, Iselius L, Yates JRW, et al. von Hippel-Lindau disease: a genetic study. J Med Genet. 1991;28(7):443–7. https://doi.org/10.1136/jmg.28.7.443.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Lonser RR, Glenn GM, Walther M, et al. von Hippel-Lindau disease. Lancet. 2003;361:2059–67. https://doi.org/10.1016/S0140-6736(03)13643-4.

    Article  CAS  PubMed  Google Scholar 

  48. Schmid S, Gillessen S, Binet I, et al. Management of von Hippel-Lindau disease: an interdisciplinary review. Oncol Res Treat. 2014;37(12):761–71. https://doi.org/10.1159/000369362.

    Article  CAS  PubMed  Google Scholar 

  49. Singh AD, Nouri M, Shields CL, Shields JA, Perez N. Treatment of retinal capillary hemangioma. Ophthalmology. 2002;109(10):1799–806. https://doi.org/10.1016/S0161-6420(02)01177-6.

    Article  PubMed  Google Scholar 

  50. Ruppert MD, Gavin M, Mitchell KT, Peiris AN. Ocular manifestations of von Hippel-Lindau disease. Cureus. 2019;11(8):e5319. https://doi.org/10.7759/cureus.5319.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Daniels A, Wiley H, Shields C, et al. The new 2020 guidelines for retinal surveillance of patients with von Hippel-Lindau disease: detailed and evidence-based guidelines. In: 44th annual macula society meeting. Miami Beach; 2020.

    Google Scholar 

  52. Annesley WH, Leonard BC. Fifteen year review of treated cases of retinal angiomatosis. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83(3):OP446.

    PubMed  Google Scholar 

  53. Lane CM, Turner G, Gregor ZJ, Bird AC. Laser treatment of retinal angiomatosis. Eye. 1989;3(1):33–8. https://doi.org/10.1038/eye.1989.5.

    Article  PubMed  Google Scholar 

  54. Blodi CF, Russell SR, Pulido JS, Folk JC. Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser. Ophthalmology. 1990;97(6):791–7. https://doi.org/10.1016/S0161-6420(90)32509-5.

    Article  CAS  PubMed  Google Scholar 

  55. Rosa RH, Goldberg MF, Richard GW. Clinicopathologic correlation of argon laser photocoagulation of retinal angiomas in a patient with von Hippel-Lindau disease followed for more than 20 years. Retina. 1996;16(2):145–56. https://doi.org/10.1097/00006982-199616020-00011.

    Article  PubMed  Google Scholar 

  56. Schmidt D, Natt E, Neumann HP. Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Eur J Med Res. 2000;5(2):47–58.

    CAS  PubMed  Google Scholar 

  57. Mainster MA. Wavelength selection in macular photocoagulation: tissue optics, thermal effects, and laser systems. Ophthalmology. 1986;93(7):952–8. https://doi.org/10.1016/S0161-6420(86)33637-6.

    Article  CAS  PubMed  Google Scholar 

  58. Gorin MB. von Hippel-Lindau disease: clinical considerations and the use of fluorescein-potentiated argon laser therapy for treatment of retinal angiomas. Semin Ophthalmol. 1992;7(3):182–91. https://doi.org/10.3109/08820539209065107.

    Article  CAS  PubMed  Google Scholar 

  59. Goldberg MF, Koenig S. Argon laser treatment of von Hippel-Lindau retinal angiomas: I. Clinical and angiographic findings. Arch Ophthalmol. 1974;92(2):121–5. https://doi.org/10.1001/archopht.1974.01010010127009.

    Article  CAS  PubMed  Google Scholar 

  60. Shields CL, Douglass A, Higgins T, Samara WA, Shields JA. Retinal hemangiomas: understanding clinical features, imaging, and therapies. Retin Today. 2015;10:61.

    Google Scholar 

  61. Wiley HE, Schachat AP, Chew EY. Hemangioblastoma of the retina and von Hippel-Lindau disease. In: Schachat AP, editor. Ryan’s retina. 6th ed. Elsevier; 2018. p. 2427–37.

    Google Scholar 

  62. Seibel I, Cordini D, Hager A, et al. Long-term results after proton beam therapy for retinal papillary capillary hemangioma. Am J Ophthalmol. 2014;158(2):381–6. https://doi.org/10.1016/j.ajo.2014.05.003.

    Article  PubMed  Google Scholar 

  63. Dahr SS, Cusick M, Rodriguez-Coleman H, et al. Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina. Retina. 2007;27(2):150–8. https://doi.org/10.1097/IAE.0b013e318030a290.

    Article  PubMed  Google Scholar 

  64. Wong WT, Liang KJ, Hammel K, Coleman HR, Chew EY. Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease. Ophthalmology. 2008;115(11):1957. https://doi.org/10.1016/j.ophtha.2008.04.033.

    Article  PubMed  Google Scholar 

  65. Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 2008;27(6):622–47. https://doi.org/10.1016/j.preteyeres.2008.09.003.

    Article  CAS  PubMed  Google Scholar 

  66. Kaur C. Hypoxia-ischemia and retinal ganglion cell damage. Clin Ophthalmol. 2008;2(4):879. https://doi.org/10.2147/opth.s3361.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Garcia-Arumí J, Sararols LH, Cavero L, Escalada F, Corcóstegui BF. Therapeutic options for capillary papillary hemangiomas. Ophthalmology. 2000;107(1):48–54. https://doi.org/10.1016/S0161-6420(99)00018-4.

    Article  PubMed  Google Scholar 

  68. Sachdeva R, Dadgostar H, Kaiser PK, Sears JE, Singh AD. Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma. Acta Ophthalmol. 2010;88(8):e334. https://doi.org/10.1111/j.1755-3768.2010.02008.x.

    Article  PubMed  Google Scholar 

  69. Schmidt-Erfurth UM, Kusserow C, Barbazetto IA, Laqua H. Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology. 2002;109(7):1256–66. https://doi.org/10.1016/S0161-6420(02)01059-X.

    Article  PubMed  Google Scholar 

  70. Papastefanou VP, Pilli S, Stinghe A, Lotery AJ, Cohen VML. Photodynamic therapy for retinal capillary hemangioma. Eye. 2013;27(3):438–42. https://doi.org/10.1038/eye.2012.259.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Kreusel KM, Bornfeld N, Lommatzsch A, Wessing A, Foerster MH. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology. 1998;105(8):1386–92. https://doi.org/10.1016/S0161-6420(98)98017-4.

    Article  CAS  PubMed  Google Scholar 

  72. Miguel D, De Frutos-Baraja JM, López-Lara F, et al. Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II. J Contemp Brachytherapy. 2018;10:347. https://doi.org/10.5114/jcb.2018.77955.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Gaudric A, Krivosic V, Duguid G, Massin P, Giraud S, Richard S. Vitreoretinal surgery for severe retinal capillary hemangiomas in von Hippel-Lindau disease. Ophthalmology. 2011;118(1):142–9. https://doi.org/10.1016/j.ophtha.2010.04.031.

    Article  PubMed  Google Scholar 

  74. Schlesinger T, Appukuttan B, Hwang T, et al. Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma. Arch Ophthalmol. 2007;125(9):1189–93. https://doi.org/10.1001/archopht.125.9.1189.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. van Overdam KA, Missotten T, Kilic E, Spielberg LH. Early surgical treatment of retinal hemangioblastomas. Acta Ophthalmol. 2017;95(1):97–102. https://doi.org/10.1111/aos.13223.

    Article  PubMed  Google Scholar 

  76. Hrisomalos FN, Maturi RK, Pata V. Long-term use of intravitreal bevacizumab (Avastin) for the treatment of von Hippel-Lindau associated retinal hemangioblastomas. Open Ophthalmol J. 2015;4:66. https://doi.org/10.2174/1874364101004010066.

    Article  CAS  Google Scholar 

  77. Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Nat Rev Cancer. 2015;15(1):55–64. https://doi.org/10.1038/nrc3844.

    Article  CAS  PubMed  Google Scholar 

  78. Li M, Kim WY. Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL. J Cell Mol Med. 2011;15(2):187–95. https://doi.org/10.1111/j.1582-4934.2010.01238.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Maxwell PH, Wlesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399(6733):271–5. https://doi.org/10.1038/20459.

    Article  CAS  PubMed  Google Scholar 

  80. Na X, Wu G, Ryan CK, Schoen SR, Di Santagnese PA, Messing EM. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1α expression in renal cell carcinomas. J Urol. 2003;170(2 I):588–92. https://doi.org/10.1097/01.ju.0000074870.54671.98.

    Article  CAS  PubMed  Google Scholar 

  81. Karimi S, Nikkhah H, Ahmadieh H, Safi S. Intravitreal injection of propranolol for the treatment of retinal capillary hemangioma in a case of von Hippel–Lindau. Retin Cases Brief Rep. 2018;14(4):305. https://doi.org/10.1097/icb.0000000000000718; Publish Ahead of Print.

    Article  Google Scholar 

  82. Albiñana V, Escribano RMJ, Soler I, et al. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease. Orphanet J Rare Dis. 2017;12:122. https://doi.org/10.1186/s13023-017-0664-7.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Klein BEK, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990;13:34. https://doi.org/10.2337/diacare.13.1.34.

    Article  CAS  PubMed  Google Scholar 

  84. Morrison JL, Hodgson LAB, Lim LL, Al-Qureshi S. Diabetic retinopathy in pregnancy: a review. Clin Experiment Ophthalmol. 2016;44:321. https://doi.org/10.1111/ceo.12760.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vanderbilt Eye Institute and Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA

    Ronal Milam & Anthony B. Daniels

Authors
  1. Ronal Milam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony B. Daniels
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony B. Daniels .

Editor information

Editors and Affiliations

  1. Surgery, Hackensack Meridian School of Medicine, Edison, NJ, USA

    Dhaval Thakor Patel

  2. Neuroendocrine Oncology Unit, VHL Clinical Care Center and Endocrine Neoplasia Translational Research Center (ENTIRE), Sheba Medical Center Tel Aviv University Faculty of Medicine, Ramat Gan, Tel Aviv, Israel

    Amit Tirosh

Rights and permissions

Reprints and permissions

Copyright information

© 2024 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Milam, R., Daniels, A.B. (2024). Retinal Hemangioblastomas. In: Patel, D.T., Tirosh, A. (eds) Von Hippel-Lindau Disease. Springer, Cham. https://doi.org/10.1007/978-3-031-53858-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-53858-2_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-53857-5

  • Online ISBN: 978-3-031-53858-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation